Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, W.-M.
Right arrow Articles by Wang, Z.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, W.-M.
Right arrow Articles by Wang, Z.-Q.
[Cancer Research 62, 6990-6996, December 1, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Synergistic Role of Ku80 and Poly(ADP-ribose) Polymerase in Suppressing Chromosomal Aberrations and Liver Cancer Formation1

Wei-Min Tong, Ulrich Cortes, M. Prakash Hande, Hiroko Ohgaki, Luciane R. Cavalli, Peter M. Lansdorp, Bassem R. Haddad and Zhao-Qi Wang2

International Agency for Research on Cancer (IARC), 69008 Lyon, France [W-M. T., U. C., H. O., Z-Q. W.]; Center for Radiological Research, College of Physicians and Surgeons, Columbia University, New York, New York 10032 [M. P. H.]; Institute for Molecular and Human Genetics, Georgetown University Medical Center, Washington DC 20007 [L. R. C., B. R. H.]; and Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada [P. M. L.]

Liver cancer is one of the major human tumors in the world. Basic and epidemiological studies have proposed that the major risk factors for liver cancer include alcohol and diet as well as infection with hepatitis B and C viruses. However, the mechanistic clues for the development of this type of cancer is largely unknown. Poly(ADP-ribose) polymerase (PARP-1) and a component of nonhomologous end-joining (NHEJ) machinery, Ku80, are two major DNA end-binding molecules that play a multifunctional role in DNA damage signaling and repair, recombination as well as the maintenance of genomic stability. Here we show that the interaction of PARP-1 and Ku80 is essential for development because PARP-1/Ku80 double null mice died at embryonic day (E) 9.5. Interestingly, haplo-insufficiency of Ku80 in PARP-1-/- mice promotes the development of hepatocellular adenoma and hepatocellular carcinoma (HCC). These tumors exhibited a multistage tumor progression associated with the loss of E-cadherin expression and the mutation of ß-catenin. Cytogenetic analysis revealed that Ku80 heterozygosity elevated chromosomal instability in PARP-1-/- cells and that these liver tumors harbored a high degree of chromosomal aberrations including fragmentations, end-to-end fusions, and recurrent nonreciprocal translocations (NRT). These features are reminiscent of human HCC. Taken together, these data implicate a synergistic function of Ku80 and PARP-1 in minimized chromosome aberrations and cancer development and suggest that defects in DNA end-processing molecules may be etiological factors in human HCC formation.




This article has been cited by other articles:


Home page
RadiologyHome page
M. Tubiana, L. E. Feinendegen, C. Yang, and J. M. Kaminski
The Linear No-Threshold Relationship Is Inconsistent with Radiation Biologic and Experimental Data
Radiology, April 1, 2009; 251(1): 13 - 22.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Tanori, M. Mancuso, E. Pasquali, S. Leonardi, S. Rebessi, V. Di Majo, M.-N. Guilly, F. Giangaspero, V. Covelli, S. Pazzaglia, et al.
PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma
Carcinogenesis, October 1, 2008; 29(10): 1911 - 1919.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
A. Decottignies
Microhomology-Mediated End Joining in Fission Yeast Is Repressed by Pku70 and Relies on Genes Involved in Homologous Recombination
Genetics, July 1, 2007; 176(3): 1403 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Ratnam and J. A. Low
Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology
Clin. Cancer Res., March 1, 2007; 13(5): 1383 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Wang, W. Wu, W. Wu, B. Rosidi, L. Zhang, H. Wang, and G. Iliakis
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Nucleic Acids Res., December 4, 2006; 34(21): 6170 - 6182.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. Harris, Z. Zhang, B. Chaubey, and V. N. Pandey
Identification of Cellular Factors Associated with the 3'-Nontranslated Region of the Hepatitis C Virus Genome
Mol. Cell. Proteomics, June 1, 2006; 5(6): 1006 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Audebert, B. Salles, and P. Calsou
Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining
J. Biol. Chem., December 31, 2004; 279(53): 55117 - 55126.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Ohsaki, K. Ueda, S. Sakakibara, E. Do, K. Yada, and K. Yamanishi
Poly(ADP-Ribose) Polymerase 1 Binds to Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Terminal Repeat Sequence and Modulates KSHV Replication in Latency
J. Virol., September 15, 2004; 78(18): 9936 - 9946.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Susse, C.-J. Scholz, A. Burkle, and L. Wiesmuller
Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells
Nucleic Acids Res., February 2, 2004; 32(2): 669 - 680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Dumon-Jones, P.-O. Frappart, W.-M. Tong, G. Sajithlal, W. Hulla, G. Schmid, Z. Herceg, M. Digweed, and Z.-Q. Wang
Nbn Heterozygosity Renders Mice Susceptible to Tumor Formation and Ionizing Radiation-Induced Tumorigenesis
Cancer Res., November 1, 2003; 63(21): 7263 - 7269.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Bertolino, W.-M. Tong, D. Galendo, Z.-Q. Wang, and C.-X. Zhang
Heterozygous Men1 Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1
Mol. Endocrinol., September 1, 2003; 17(9): 1880 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Bertolino, W.-M. Tong, P. L. Herrera, H. Casse, C. X. Zhang, and Z.-Q. Wang
Pancreatic {beta}-Cell-specific Ablation of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene Causes Full Penetrance of Insulinoma Development in Mice
Cancer Res., August 15, 2003; 63(16): 4836 - 4841.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.